A detailed history of Wells Fargo & Company transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 185,058 shares of BTAI stock, worth $64,770. This represents 0.0% of its overall portfolio holdings.

Number of Shares
185,058
Previous 133,676 38.44%
Holding current value
$64,770
Previous $171,000 34.5%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$0.53 - $1.34 $27,232 - $68,851
51,382 Added 38.44%
185,058 $112,000
Q2 2024

Aug 13, 2024

BUY
$1.14 - $2.97 $12,072 - $31,452
10,590 Added 8.6%
133,676 $171,000
Q1 2024

May 10, 2024

BUY
$1.95 - $4.04 $88,251 - $182,838
45,257 Added 58.15%
123,086 $347,000
Q4 2023

Feb 09, 2024

BUY
$2.32 - $5.51 $6,751 - $16,034
2,910 Added 3.88%
77,829 $229,000
Q3 2023

Nov 13, 2023

SELL
$2.49 - $11.85 $6,130 - $29,174
-2,462 Reduced 3.18%
74,919 $189,000
Q2 2023

Aug 15, 2023

BUY
$6.39 - $28.58 $190,230 - $850,826
29,770 Added 62.53%
77,381 $515,000
Q1 2023

May 12, 2023

BUY
$17.7 - $33.24 $532,380 - $999,792
30,078 Added 171.55%
47,611 $888,000
Q4 2022

Feb 13, 2023

SELL
$10.25 - $22.43 $11,972 - $26,198
-1,168 Reduced 6.25%
17,533 $376,000
Q3 2022

Nov 14, 2022

BUY
$11.19 - $17.89 $20,936 - $33,472
1,871 Added 11.12%
18,701 $221,000
Q2 2022

Aug 12, 2022

BUY
$9.03 - $21.55 $27,857 - $66,481
3,085 Added 22.44%
16,830 $222,000
Q1 2022

May 16, 2022

SELL
$15.0 - $22.83 $89,385 - $136,043
-5,959 Reduced 30.24%
13,745 $288,000
Q4 2021

Feb 14, 2022

BUY
$20.12 - $35.09 $198,966 - $347,005
9,889 Added 100.75%
19,704 $400,000
Q3 2021

Nov 15, 2021

BUY
$23.84 - $32.03 $8,558 - $11,498
359 Added 3.8%
9,815 $298,000
Q2 2021

Aug 16, 2021

SELL
$29.06 - $38.83 $90,783 - $121,304
-3,124 Reduced 24.83%
9,456 $275,000
Q1 2021

May 13, 2021

SELL
$39.04 - $64.6 $717,047 - $1.19 Million
-18,367 Reduced 59.35%
12,580 $542,000
Q4 2020

Feb 09, 2021

BUY
$42.46 - $56.58 $798,587 - $1.06 Million
18,808 Added 154.94%
30,947 $1.43 Million
Q3 2020

Nov 05, 2020

SELL
$37.44 - $64.63 $119,995 - $207,139
-3,205 Reduced 20.89%
12,139 $526,000
Q2 2020

Aug 13, 2020

BUY
$17.62 - $58.71 $125,912 - $419,541
7,146 Added 87.17%
15,344 $813,000
Q1 2020

May 14, 2020

BUY
$12.26 - $41.14 $100,507 - $337,265
8,198 New
8,198 $184,000

Others Institutions Holding BTAI

About BioXcel Therapeutics, Inc.


  • Ticker BTAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,022,500
  • Market Cap $9.81M
  • Description
  • BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...
More about BTAI
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.